πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8933105

Pyrrole compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8933069

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8932853

Method for manufacturing pancreatic-hormone-producing cells

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8927718

Fused heterocyclic ring derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8927557

Methylpyrrolopyrimidinecarboxamides

TAKEDA GMBH Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8927016

Producing a sustained-release preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8926969

Anti-CD38 antibodies

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8920812

Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

Takeda Vaccines, Inc. Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8921379

Fused ring compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8921358

Apoptosis signal-regulating kinase 1 inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8921354

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8921326

Sustained-release composition and method for producing the same

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8920840

Enteric tablet

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8916566

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8916551

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8916549

Thienooxazepine derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8907089

Fused heterocyclic ring derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906901

Administration of dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906411

Pre-compacted calcium-containing compositions

TAKEDA NYCOMED AS Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8901309

Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8901171

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8901141

Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharma

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8900638

Solid preparation comprising alogliptin and metformin hydrochloride

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895591

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted